CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation.

BACKGROUND: Coronavirus-induced disease 19 (COVID-19) infects more than three hundred and sixty million patients worldwide, and people with severe symptoms frequently die of acute respiratory distress syndrome (ARDS). Recent studies indicated that excessive neutrophil extracellular traps (NETs) contributed to immunothrombosis, thereby leading to extensive intravascular coagulopathy and multiple organ dysfunction. Thus, understanding the mechanism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced NET formation would be helpful to reduce thrombosis and prevent ARDS in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. METHODS: We incubated SARS-CoV-2 with neutrophils in the presence or absence of platelets to observe NET formation. We further isolated extracellular vesicles from COVID-19 patients' sera (COVID-19-EVs) to examine their ability to induce NET formation. RESULTS: We demonstrated that antagonistic mAbs against anti-CLEC5A mAb and anti-TLR2 mAb can inhibit COVID-19-EVs-induced NET formation, and generated clec5a-/-/tlr2-/- mice to confirm the critical roles of CLEC5A and TLR2 in SARS-CoV-2-induced lung inflammation in vivo. We found that virus-free extracellular COVID-19 EVs induced robust NET formation via Syk-coupled C-type lectin member 5A (CLEC5A) and TLR2. Blockade of CLEC5A inhibited COVID-19 EVs-induced NETosis, and simultaneous blockade of CLEC5A and TLR2 further suppressed SARS-CoV-2-induced NETosis in vitro. Moreover, thromboinflammation was attenuated dramatically in clec5a-/-/tlr2-/- mice. CONCLUSIONS: This study demonstrates that SARS-CoV-2-activated platelets produce EVs to enhance thromboinflammation via CLEC5A and TLR2, and highlight the importance of CLEC5A and TLR2 as therapeutic targets to reduce the risk of ARDS in COVID-19 patients.

Morphogenesis of the hepatitis B virion and subviral particles in the liver of transgenic mice.

Up to date, no ultrastructure showing the HBV budding site has ever been reported. In this study, the liver of transgenic mice expressing a high titer of HBV was processed for cryo-ultrathin section electron microscopy. This approach preserves membrane structures very well and thus allowed us to find HBV (Dane particles) and subviral particles (spherical and filamentous form) present separately inside the lumen of the endoplasmic reticulum (ER). Envelopment of single core particle by the ER was found near the Golgi region and mature Dane particles usually resided singularly in a 70-90 nm vesicle at the end of ER or near to mitochondria. Filamentous particles, either in an array or as a single filament inside various sizes of vesicles, were most frequently; these particles were found adjacent to the Golgi region or bile canaliculi. The formation of 22-nm spherical particles seems to occur inside the ER by a transition from preformed filaments to a structure similar to beads on a string. This study is the first report to demonstrate a serial process by which hepatitis B virion assembly takes place in the ER region and distinguishes two separate routes for the morphogenesis of virions and subviral particles.